Desmoid-Type Fibromatosis—Clinical Study of an Uncommon Disease

  • Sreekanth S. KumarEmail author
  • K. Rajeevan
  • E. Devarajan
Original Article


Desmoid-type fibromatosis is an uncommon disease which mimics sarcoma but is more locally aggressive but with less metastatic potential than sarcoma. Diagnosis is difficult and treatment protocols have changed to include more non-surgical options as compared with sarcoma. This is a retrospective study of the clinical presentation, imaging findings, treatment given, and outcomes of pathologically proven desmoid-type fibromatosis patients who presented to government medical college Kozhikode.


Desmoid Fibromatosis Non-surgical Tamoxifen 



  1. 1.
    Li M, Cordon-Cardo C, Gerlad WL et al (1996) Desmoid type fibromatosis is a clonal process. Hum Pathol 27:9CrossRefGoogle Scholar
  2. 2.
    Fletcher JA, Bridge JA, Hogendorn PCW (2013) WHO classification of tumours of soft tissue and bone, 4th edn. IARC, LyonGoogle Scholar
  3. 3.
    Fiore M, Coppola S, Cannell AJ (2014) Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk. Ann Surg 259(5):973–978CrossRefGoogle Scholar
  4. 4.
    Dinauer PA, Brixey CJ, Moncur JT, Fanburg-Smith JC, Murphey MD (2007) Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults. Radiographics 27(1)CrossRefGoogle Scholar
  5. 5.
    Otero S, Moskovic EC, Strauss DC (2015) Desmoid type fibromatosis. Clin Radiol 70(9):1038–1045CrossRefGoogle Scholar
  6. 6.
    Kamali F, Wang WL, Guadanoio BA (2016) MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours. Br J Radiol 89(1058):20150308CrossRefGoogle Scholar
  7. 7.
    Shinagare AB, Ramaiya NH, Jagannathan JP, Krajewski KM, Giardino AA, Butrynski JE, Raut CP (2011) A to Z of desmoid tumors. AJR Am J Roentgenol 197(6):W1008–W1014CrossRefGoogle Scholar
  8. 8.
    Murphey MD, Ruble CM, Tyszko SM, Zbojniewicz AM, Potter BK, Miettinen M (2009) From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation. Radiographics 29(7):2143–2183CrossRefGoogle Scholar
  9. 9.
    Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C (2005) Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 29(5):653–659CrossRefGoogle Scholar
  10. 10.
    Weiss SW, Langloss JM, Shmookler BM (1986) Estrogen receptor protein in bone and soft tissue tumors. Lab Invest 54(sl)Google Scholar
  11. 11.
    McDougall A, McGarrity G (1979) Extra-abdominal desmoid tumours. J Bone Joint Surg (Br) 61(s.l.)Google Scholar
  12. 12.
    Pignatti G, Barbanti-Brodano G, Ferrari D (2000) Extraabdominal desmoid tumor. a study of 83 cases. Clin Orthop 375(s.l.):207–213CrossRefGoogle Scholar
  13. 13.
    Fong Y, Rosen PP, Brennan MF (1993) Multifocal desmoids. Surgery 114(s.l.)Google Scholar
  14. 14.
    The desmoid tumour. Not a benign disease, Posner MC, Shiu MH, Newsome JL (1989) Arch Surg 124(2)Google Scholar
  15. 15.
    Huang K, Fu H, Shi Y (2009) Prognostic factors for desmoid tumours: a 20 year experience of a single institution. J Surg Oncol 100(7):563–569CrossRefGoogle Scholar
  16. 16.
    Peng PD, Hyder O, Mavros MN (2012) Management and recurrence patterns of desmoid tumors: a multi institutional analysis of 211 patients. Ann Surg Oncol 19(13):4036–4042CrossRefGoogle Scholar
  17. 17.
    Mullen JT, Delaney TF, Kobayashi WK (2012) Desmoid tumour: analysis of prognostic factors and outcomes in a surgical series. Ann Surg Oncol 19(13):4028–4035CrossRefGoogle Scholar
  18. 18.
    Desmoid tumours treated with triphenylethylenes, Brooks MD, Ebbs SR, Colletta AA (1992) Eur J Cancer 28AGoogle Scholar
  19. 19.
    Izes JK, Zinman LN, Larsen CR (1996) Regression of large pelvic desmoid tumour by tamoxifen and sulindac. Urology 47:756–759CrossRefGoogle Scholar
  20. 20.
    Pilz T, Pilgrim TB, Bisogno G (1999) Chemotherapy in fibromatoses of childhood and adolescence: results from the cooperative soft tissue sarcoma study (CWS) and the Italian Cooperative study group(ICG-AIEOP). Klin Padiatr 211Google Scholar
  21. 21.
    Weiss AJ, Lackman RD (1989) low dose chemotherapy of desmoid tumours. Cancer 64:1192–1194CrossRefGoogle Scholar
  22. 22.
    Bonvalot S, Eldweny H, Haddad V (2008) Extra abdominal fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol 34(4):462–468CrossRefGoogle Scholar
  23. 23.
    Nakayama T, Tsuboyama T, Toguchida J (2008) Natural course of desmoid-type fibromatosis. J Orthop Sci 34(4)Google Scholar
  24. 24.
    Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E (2006) Aggressive fibromatosis: MRI features with pathologic correlation. Am J Roentgenol 186(1):slCrossRefGoogle Scholar
  25. 25.
    Kasper B, Baumgarten C, Garcia J, Bonvalot S (2017) An update on the management of sporadic desmoid-type fibromatosis: a european consensus initiative between sarcoma PAtients EuroNet(SPAEN) and European organisation for research and Treatement of Cancer (EORTC)/Soft tissue and bone sarcoma group (STBSG). Ann Oncol 28(10):s.l.CrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  • Sreekanth S. Kumar
    • 1
    Email author
  • K. Rajeevan
    • 2
  • E. Devarajan
    • 3
  1. 1.Department of Surgical OncologyGovernment Medical College KozhikodeKozhikodeIndia
  2. 2.Department of PathologyGovernment Medical College KozhikodeKozhikodeIndia
  3. 3.Department of RadiologyGovernment Medical College KozhikodeKozhikodeIndia

Personalised recommendations